wee-1.3 Antibody

Introduction to WEE-Antibody

The WEE-1.3 antibody is a specialized tool for detecting the Caenorhabditis elegans WEE-1.3 kinase, a homolog of the human WEE1 and Myt1 kinases. This antibody enables researchers to study WEE-1.3's role in cell cycle regulation, particularly during oocyte maturation, embryonic development, and germline proliferation . Its applications span immunofluorescence, protein localization studies, and functional analyses in genetic screens .

Target Protein Overview

WEE-1.3 is a membrane-associated tyrosine/threonine kinase that negatively regulates the G2/M transition by phosphorylating cyclin-dependent kinase CDK-1 . Key functions include:

• Cell cycle control: Prevents premature mitotic entry by inhibiting CDK-1 activity .

• Germline development: Essential for oocyte maturation, spermatogenesis, and embryonic viability .

• Protein interactions: Partners with CDC-25.2 phosphatase and CDK-1/CYB-1 complexes to regulate intestinal cell divisions .

Immunofluorescence and Localization Studies

The WEE-1.3 antibody has been critical in identifying subcellular localization patterns:

• Perinuclear and cytoplasmic punctae: Observed in oocytes and embryos, colocalizing with endoplasmic reticulum (ER) markers .

• Nuclear accumulation: Reported in proteasomal subunit-depletion mutants (e.g., rpn-10), suggesting regulation by proteasome activity .

Functional Genetic Analyses

• RNAi phenocopy: Depletion causes precocious oocyte maturation, reduced NOP1 staining, and AIR-2/pH3 marker mislocalization .

• Suppressor screens: Identified interactions with pam-1 aminopeptidase, rescuing embryonic lethality and polarity defects .

WEE-1.3 in Oocyte Maturation

Proteasomal Regulation

Technical Validation

• Specificity: Validated via CRISPR/Cas9-generated GFP-tagged strains (N-terminal: gfp::wee-1.3; C-terminal: wee-1.3::gfp), showing identical localization to antibody-stained samples .

• Functional assays: Antibody staining confirmed loss of WEE-1.3 in RNAi-depleted germlines, correlating with pH3 and AIR-2 marker dysregulation .

Limitations and Future Directions

• Cross-reactivity: Current data focus on C. elegans; homology to human WEE1 requires further validation .

• Therapeutic potential: While WEE1 inhibitors (e.g., AZD1775) are in clinical trials for cancers, WEE-1.3 studies remain foundational for understanding conserved cell cycle mechanisms .